- Home
- IPHA vs MAV Comparison
IPHA vs MAV Comparison
Compare IPHA & MAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- MAV
- Stock Information
- Founded
- IPHA 1999
- MAV 2003
- Country
- IPHA France
- MAV United States
- Employees
- IPHA N/A
- MAV N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- MAV Finance Companies
- Sector
- IPHA Health Care
- MAV Finance
- Exchange
- IPHA Nasdaq
- MAV Nasdaq
- Market Cap
- IPHA 160.1M
- MAV 184.1M
- IPO Year
- IPHA 2019
- MAV N/A
- Fundamental
- Price
- IPHA $1.83
- MAV $8.23
- Analyst Decision
- IPHA Strong Buy
- MAV
- Analyst Count
- IPHA 1
- MAV 0
- Target Price
- IPHA $11.00
- MAV N/A
- AVG Volume (30 Days)
- IPHA 10.0K
- MAV 66.2K
- Earning Date
- IPHA 03-27-2025
- MAV 01-01-0001
- Dividend Yield
- IPHA N/A
- MAV 4.30%
- EPS Growth
- IPHA N/A
- MAV N/A
- EPS
- IPHA N/A
- MAV N/A
- Revenue
- IPHA $20,831,349.00
- MAV N/A
- Revenue This Year
- IPHA $209.83
- MAV N/A
- Revenue Next Year
- IPHA $83.15
- MAV N/A
- P/E Ratio
- IPHA N/A
- MAV N/A
- Revenue Growth
- IPHA N/A
- MAV N/A
- 52 Week Low
- IPHA $1.29
- MAV $6.37
- 52 Week High
- IPHA $3.51
- MAV $8.34
- Technical
- Relative Strength Index (RSI)
- IPHA 33.33
- MAV 44.97
- Support Level
- IPHA $1.82
- MAV $8.25
- Resistance Level
- IPHA $2.21
- MAV $8.34
- Average True Range (ATR)
- IPHA 0.07
- MAV 0.06
- MACD
- IPHA -0.03
- MAV -0.01
- Stochastic Oscillator
- IPHA 6.74
- MAV 8.33
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax and as a secondary objective to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.